A Critical Review of Validation, Blind Testing, and Real- World Use of Alchemical Protein-Ligand Binding Free Energy Calculations.

Protein-ligand binding is among the most fundamental phenomena underlying all molecular biology, and a greater ability to more accurately and robustly predict the binding free energy of a small molecule ligand for its cognate protein is expected to have vast consequences for improving the efficiency of pharmaceutical drug discovery. We briefly reviewed a number of scientific and technical advances that have enabled alchemical free energy calculations to recently emerge as a preferred approach, and critically considered proper validation and effective use of these techniques. In particular, we characterized a selection bias effect which may be important in prospective free energy calculations, and introduced a strategy to improve the accuracy of the free energy predictions.

[1]  Peter A. Kollman,et al.  Free energy perturbation simulations of the inhibition of thermolysin: prediction of the free energy of binding of a new inhibitor , 1989 .

[2]  Alexander D. MacKerell,et al.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. , 2012, Journal of chemical theory and computation.

[3]  Edward D Harder,et al.  How To Deal with Multiple Binding Poses in Alchemical Relative Protein–Ligand Binding Free Energy Calculations , 2015, Journal of chemical theory and computation.

[4]  M. Levitt,et al.  Computer simulation of protein folding , 1975, Nature.

[5]  Michael R. Shirts,et al.  Statistically optimal analysis of samples from multiple equilibrium states. , 2008, The Journal of chemical physics.

[6]  B. Berne,et al.  Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2). , 2011, The journal of physical chemistry. B.

[7]  J. Kirkwood Statistical Mechanics of Fluid Mixtures , 1935 .

[8]  William L Jorgensen,et al.  Computer-aided discovery of anti-HIV agents. , 2016, Bioorganic & medicinal chemistry.

[9]  Peter A. Kollman,et al.  FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .

[10]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[11]  Samuel Genheden,et al.  A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities , 2014, J. Chem. Inf. Model..

[12]  W. L. Jorgensen,et al.  Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field , 2015, Journal of chemical theory and computation.

[13]  Wilfred F. van Gunsteren,et al.  An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase , 2001, J. Comput. Chem..

[14]  Julien Michel,et al.  Blinded predictions of binding modes and energies of HSP90-α ligands for the 2015 D3R grand challenge. , 2016, Bioorganic & medicinal chemistry.

[15]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[16]  Scott P. Brown,et al.  Healthy skepticism: assessing realistic model performance. , 2009, Drug discovery today.

[17]  Kenneth M. Merz,et al.  Drug Design : Structure-and Ligand-Based Approaches , 2017 .

[18]  Christophe Chipot,et al.  Efficient determination of protein-protein standard binding free energies from first principles. , 2013, Journal of chemical theory and computation.

[19]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[20]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[21]  Jennifer L. Knight,et al.  Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors. , 2013, Journal of chemical theory and computation.

[22]  Christopher Jarzynski,et al.  Comparison of far-from-equilibrium work relations , 2007 .

[23]  Charles H. Bennett,et al.  Efficient estimation of free energy differences from Monte Carlo data , 1976 .

[24]  W. Lipscomb,et al.  Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity. , 2007, Journal of the American Chemical Society.

[25]  Julian Tirado-Rives,et al.  Potential energy functions for atomic-level simulations of water and organic and biomolecular systems. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Wang,et al.  Replica Monte Carlo simulation of spin glasses. , 1986, Physical review letters.

[27]  D. Case,et al.  Derivation of fixed partial charges for amino acids accommodating a specific water model and implicit polarization. , 2013, The journal of physical chemistry. B.

[28]  J. Andrew McCammon,et al.  Dynamics and design of enzymes and inhibitors , 1986 .

[29]  W. L. Jorgensen,et al.  Performance of Protein-Ligand Force Fields for the Flavodoxin-Flavin Mononucleotide System. , 2016, The journal of physical chemistry letters.

[30]  H. Berman The Protein Data Bank: a historical perspective. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[31]  Wilfred F van Gunsteren,et al.  Practical Aspects of Free-Energy Calculations: A Review. , 2014, Journal of chemical theory and computation.

[32]  R. Brüschweiler,et al.  NMR-based protein potentials. , 2010, Angewandte Chemie.

[33]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[34]  Lingle Wang,et al.  On achieving high accuracy and reliability in the calculation of relative protein–ligand binding affinities , 2012, Proceedings of the National Academy of Sciences.

[35]  Atli Thorarensen,et al.  Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free‐Energy Perturbation (FEP) , 2016, ChemMedChem.

[36]  Christophe Chipot,et al.  Good practices in free-energy calculations. , 2010, The journal of physical chemistry. B.

[37]  Daniel Cappel,et al.  Accurate Binding Free Energy Predictions in Fragment Optimization , 2015, J. Chem. Inf. Model..

[38]  Diwakar Shukla,et al.  OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation. , 2013, Journal of chemical theory and computation.

[39]  R. Dror,et al.  Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.

[40]  Thomas Fox,et al.  Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..

[41]  R. Zwanzig High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .

[42]  Jennifer L. Knight,et al.  Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.

[43]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[44]  William L Jorgensen,et al.  Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.

[45]  X. Langlois,et al.  Pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors. , 2015, ACS medicinal chemistry letters.

[46]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[47]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[48]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[49]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. , 2013, Journal of chemical theory and computation.

[50]  W. L. Jorgensen,et al.  Monte Carlo simulation of differences in free energies of hydration , 1985 .

[51]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[52]  M. Hann Molecular obesity, potency and other addictions in drug discovery , 2011 .

[53]  M. Erion,et al.  Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach. , 2001, Journal of the American Chemical Society.

[54]  K. Dill,et al.  Blind prediction of charged ligand binding affinities in a model binding site. , 2013, Journal of molecular biology.

[55]  M. Karplus,et al.  Dynamics of folded proteins , 1977, Nature.

[56]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[57]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[58]  Gisbert Schneider,et al.  Virtual screening: an endless staircase? , 2010, Nature Reviews Drug Discovery.